Back
Seres Therapeutics Vs. Protagonist Therapeutics Industry Stock Comparison
Sell
33
MCRB
Seres Therapeutics
Last Price:
0.74
Seasonality Move:
-11.95%
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
24.67
Seasonality Move:
25.26%
Sell
33
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.74. The Score for MCRB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $24.66. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.74
The current trend is relatively stagnant and MCRB is experiencing slight selling pressure.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $24.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 50.91 | Buy |
| Chaikin Money Flow: | -1166718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.64 - 0.78) | Buy |
| Bollinger Bands (100): | (0.79 - 1.25) | Sell |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.78 | Sell |
| Relative Strength Index (14 RSI): | 34.2 | Sell |
| Chaikin Money Flow: | -333161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.1 - 28.5) | Sell |
| Bollinger Bands (100): | (22.7 - 29.16) | Sell |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Buy |
| 20-day SMA: | 0.7 | Buy |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 1.87 | Sell |
| 8-day EMA: | 0.69 | Buy |
| 20-day EMA: | 0.71 | Buy |
| 50-day EMA: | 0.83 | Sell |
| 200-day EMA: | 1.92 | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.79 | Sell |
| 20-day SMA: | 27.08 | Sell |
| 50-day SMA: | 28.35 | Sell |
| 200-day SMA: | 21.79 | Buy |
| 8-day EMA: | 25.94 | Sell |
| 20-day EMA: | 26.81 | Sell |
| 50-day EMA: | 27.13 | Sell |
| 200-day EMA: | 23.49 | Buy |
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.30 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Seres Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||